Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, especially for cancers where therapy options remain limited. Make use of the links below to learn a lot more about our portfolio of cytokine-based immunotherapy candidates. https://financefeeds.com/isda-report-finds-87-1-of-companies-use-derivatives-to-manage-business/